#in silico validation
Discover 2 curated intelligence briefings related to this specific topic.
Economics & Money
The Great Patent Cliff: A New Era of Pharmaceutical Accessibility
The pharmaceutical landscape is hitting a critical inflection point. With billions in revenue at risk as blockbuster patents expire, we are witnessing a systemic shift in how medicine is priced and distributed globally.
Read Analysis
Technology & Innovation
Repurposing Existing Molecules Slashes Clinical Risk
A master practitioner's approach to constructing a drug repurposing pipeline, leveraging public bio-databases to bypass the multi-billion dollar gamble of de novo drug discovery.
Read Analysis